NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$11.02
-0.07 (-0.63%)
▼
5d:
-3.67%
30d:
+33.74%
90d:
+33.25%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEO appears deeply undervalued. Market expects -10.3% annual earnings decline despite 131% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: NEO appears deeply undervalued. Market expects -10.3% annual earnings decline despite 131% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.02
0.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $11.02, which is considered slightly high relative to its 30-day fair value range of $8.72 to $10.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.4) compared to its historical average (42.2). Remarkably, the market is currently pricing in an annual earnings decline of 10.3% over the next few years. This pessimistic expectation contrasts with the company's recent 130.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NEO is in a downtrend. Immediate support is located at $9.20, while resistance sits at $11.57.
Market Sentiment: NEO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.06 (+35.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEO is in a downtrend. Immediate support is located at $9.20, while resistance sits at $11.57.
Market Sentiment: NEO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.06 (+35.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.72 -
$10.98
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.8% below Wall St target ($15.06)
Trading Range Analysis
30-Day Trading Range
$8.72 -
$10.98
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.20
Resistance Level
$11.58
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.42
Wall Street Target
$15.06
(+35.8%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
130.6%
Profit Margin
-13.3%
Valuation Discount vs History
-10.3% cheaper
PE vs Historical
30.4 vs 42.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.3%
(market-implied from PE analysis)
1-Year Target
$9.98
(-10%)
2-Year Target
$8.98
(-19%)
3-Year Target
$8.08
(-27%)
3-Yr Target (if PE normalizes)
(PE: 30→42)
$11.22
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.4, Growth: 102.6%)
$37.43
(+238%)
Base:
(SPY PE: 21.8, Growth: 102.6%)
$26.80
(+142%)
Bear:
(PE: 18.5, Growth: 102.6%)
$22.78
(+105%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.4 to 42.2
Stabilization Target:
$15.39
(+38.7%)
PE Expansion Potential:
+38.7%
Share & Embed Analysis
Last updated: June 16, 2026 12:14 PM ET
Data refreshes hourly during market hours. Next update: 1:14 PM
Data refreshes hourly during market hours. Next update: 1:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Warren Stone
SELL
22128 shares
2026-01-20
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 63 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$141 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
